1. Home
  2. KMT vs KARD Comparison

KMT vs KARD Comparison

Compare KMT & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$29.72

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$20.10

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KMT
KARD
Founded
1938
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
KMT
KARD
Price
$29.72
$20.10
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$36.00
N/A
AVG Volume (30 Days)
1.7M
215.1K
Earning Date
05-06-2026
N/A
Dividend Yield
2.08%
N/A
EPS Growth
268.33
N/A
EPS
4.42
N/A
Revenue
$2,356,698,000.00
N/A
Revenue This Year
$14.24
N/A
Revenue Next Year
$7.57
N/A
P/E Ratio
$6.83
N/A
Revenue Growth
19.82
N/A
52 Week Low
$20.35
$19.58
52 Week High
$43.81
$27.00

Technical Indicators

Market Signals
Indicator
KMT
KARD
Relative Strength Index (RSI) 39.57 45.82
Support Level $28.23 $19.67
Resistance Level $35.50 $23.02
Average True Range (ATR) 0.99 1.40
MACD -0.03 0.03
Stochastic Oscillator 36.20 23.97

Price Performance

Historical Comparison
KMT
KARD

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: